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Open abdomen treatment following endovascular repair of
ruptured abdominal aortic aneurysms
Abstract
BACKGROUND: Open abdomen treatment (OAT) is considered a lifesaving procedure in patients with
abdominal compartment syndrome (ACS) after endovascular or open intervention for ruptured
abdominal aortic aneurysms (RAAA). Standardized treatment methods and algorithms for its use are
still lacking. The high, published mortality rates may reflect difficulties in detecting and treating ACS,
especially in patients treated by emergency endovascular aneurysm repair (eEVAR). Presented are
standardized algorithms for OAT, including a new technique using the vacuum-assisted closure (VAC)
system developed during 10 years of experience with eEVAR for RAAA. METHODS: We
retrospectively analyzed 102 patients with RAAA treated by eEVAR from January 1998 to April 2008.
Abdominal decompression was done when intravesical pressure >20 mm Hg or when abdominal
perfusion pressure was <50 to 60 mm Hg and concomitant organ deterioration occurred. OAT was
initially done with a subcutaneously sutured plastic bag or with a nonsutured zipper drape combined
with a VAC device (VAC/ETHIZIP; KCI International Inc, Amstelveen, The Netherlands; Ethicon,
Somerville, NJ). All patients were switched to VAC/ETHIZIP as soon as possible. Dressings were
generally changed every 3 to 5 days. Intra-abdominal pressure was monitored until stability was
observed after delayed direct abdominal closure. RESULTS: Overall 30-day mortality for eEVAR was
13% (13 of 102); 8% (7 of 82) for patients without ACS and 30% (6 of 20) for those with ACS.
Decompression for ACS was needed in 20 patients (20%) primarily during the intervention (n = 14) or
secondarily in the intensive care unit (n = 6). Six of 20 (30%) patients requiring OAT died <or=30 days
(4 primary, 2 secondary). A mean of 3.6 (range, 1-12) planned second-look interventions were done per
patient at an interval of 3 to 5 days. No bowel lesions were observed. Four patients required antibiotic
therapy for abdominal infection, and all infections resolved. Delayed abdominal wall closure (direct
closure, 11; closure with polypropylene mesh, 3; bilateral anterior rectus abdominis sheath turnover flap,
1) was achieved after a median of 6 days (range, 1-47 days). CONCLUSION: The use of standardized
novel techniques and a treatment protocol and algorithm for OAT after eEVAR for RAAA were feasible
and safe. It decreased the workload of the medical and nursing staff, enhanced patient comfort because
the need for dressing changes was minimized, and likely contributed to lower overall mortality in
RAAA patients. Delayed direct fascial closure was possible in most patients.
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Abstract
Introduction:
Open abdomen treatment (OAT) is considered a life saving procedure in patients with 
abdominal compartment syndrome (ACS) after endovascular or open intervention for 
ruptured abdominal aortic aneurysms (RAAA). However, standardized treatment methods and 
algorithms for its use are still lacking.  Moreover, the high published mortality rates may 
reflect difficulties in detecting and treating ACS, especially in patients treated by emergency 
endovascular aneurysm repair (eEVAR) who do not primarily undergo laparotomy. 
Standardized algorithms for OAT including a new technique using the vacuum assisted 
closure system developed during our 10 years experience with eEVAR for RAAA are
presented.
Patients and methods:
We retrospectively analyzed 102 patients with RAAA treated by eEVAR from January 1998 
to April 2008. Abdominal decompression was carried out when intravescical pressure 
exceeded 20 mm Hg or abdominal perfusion pressure (systemic mean pressure minus 
intraabdominal pressure) fell below 50-60 mm Hg and concomitant organ deterioration
occurred. On the basis of several key criteria, OAT was initially carried out either with a 
subcutaneously sutured plastic bag or with a non-sutured zipper drape combined with a 
vacuum assisted wound closure device (VAC/ETHIZIP). All patients were switched to 
VAC/ETHIZIP as soon as possible. Dressing changes were generally done every 3-5 days.
Intraabdominal pressure was monitored until stability was observed after delayed direct 
abdominal closure.
Results:
Overall thirty day mortality for eEVAR was 13% (13/102). Thirty day mortality for the cohort 
without ACS was 8% (7/82) and for the cohort with ACS 30% (6/20). Decompression for 
ACS was needed in 20/102 (20%) patients, either primarily during the intervention (n=14) or 
secondarily in the ICU (n=6). Six of 20 (30%) patients requiring OAT died within 30 days
(primary OAT, 4, secondary OAT, 2). A mean of 3.6 (min: 1, max: 12) planned second look 
interventions were done per patient with an interval between 3-5 days. No bowel lesions were 
observed during OAT. Abdominal infection requiring antibiotic therapy was encountered in 4 
patients. All infections resolved under antibiotic therapy. Delayed closure of the abdominal 
wall (direct closure, 11, closure with polypropylene mesh, 3, bilateral anterior rectus 
abdominis sheath turnover flap, 1) was achieved after a median of 6 days (min: 1 day, max: 
47 days). 
Conclusion:
The use of standardized novel techniques and a treatment protocol and algorithm for OAT 
after eEVAR for RAAA proved to be feasible and safe. It decreased the work load of the 
medical and nursing staff and enhanced patient comfort as the need for dressing changes was 
minimized.  We believe it also contributed to lower overall mortality in RAAA patients.  
Delayed direct fascial closure was possible in the majority of patients.
Keywords: abdominal compartment syndrome; ACS; ruptured abdominal aortic aneurysm; 
RAAA; open abdomen treatment; vacuum assisted wound closure; topical negative pressure; 
EVAR; outcome
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Introduction
Open abdomen treatment (OAT) is considered a life saving procedure in patients with 
abdominal compartment syndrome (ACS) after endovascular or open intervention for 
ruptured abdominal aortic aneurysms (RAAA).1-9 Since its first description by Fietsam in this 
patient cohort2, many technical reports have been published. However, clear treatment 
algorithms are still lacking and the high mortality rates published10 may reflect difficulties in 
detecting and treating ACS5. This is especially true for patients treated by emergency 
endovascular aneurysm repair (eEVAR) who do not undergo a laparotomy as part of their 
primary procedure.11-14 The aim of this study is to report on our 10-years experience with the 
management of patients requiring OAT following eEVAR for RAAA. A further objective of 
this report is to provide an algorithm for the diagnosis of intra-abdominal hypertension and 
abdominal compartment syndrome and to demonstrate a standardized method for performing 
OAT.
Patients and methods
From January 1998 to April 2008, 102/212 consecutive patients with RAAA have been 
treated by eEVAR in our tertiary referral center. Mean age was 73±9 years (min:48, max 90 
years). Aneurysm rupture, defined as blood outside the aortic wall, was confirmed by 
computerized tomographic scans (CT angiography) in all patients. In 64 blood was present in 
the retroperitoneum, in 33 it was present in the peritoneal cavity, and in 5 it was present in the 
duodenum (aorto-duodenal fistula). Critical clinical data were prospectively collected and 
retrospectively analyzed. All patient charts were systematically reviewed retrospectively for 
details concerning ACS. The study was approved by the institutional review board. 
Patient monitoring. For all patients with RAAA but in particular for patients treated by 
eEVAR, a proactive approach to detection and treatment of intraabdominal hypertension 
*Manuscript
(IAH) is critical. This group of patients is at high risk for development of ACS and therefore, 
close monitoring of intravescical pressure (corresponds to intraabdominal pressure) and organ 
function is crucial in order to detect critical IAH. Intravesical pressure (IVP) measurement 
was initiated during EVAR and repeated every hour following the procedure. Intermittent IVP 
measurement was carried out with a standard Foley catheter and volume priming with 50 ml 
normal saline in the supine position during end expiration.3, 15 The mid-axillary line served as 
zero reference. Furthermore, urinary output, respiratory function and indices for bowel 
ischemia (blood lactate and lactate dehydrogenase elevation) were closely monitored. Close 
surveillance of IVP and organ function was continued in all patients either with or without 
abdominal decompression for the duration of IAH. Importantly, this surveillance was 
continued during the whole course of stepwise approximation of the fascial borders and 
subsequent fascial closure following abdominal decompression.
Open abdomen treatment. Abdominal decompression after eEVAR was done either during the 
primary intervention or secondarily in the ICU. Indication for surgical decompression was 
based on IVP >20 mm Hg or abdominal perfusion pressure (systemic mean pressure minus 
intraabdominal pressure) <50-60 mm Hg and new development of organ dysfunction or when 
patients fulfilled at least 1 criterion from table 1.
The general algorithm of open abdomen treatment for all RAAA patients in our institution is 
illustrated in figure 1. To avoid intra-abdominal hypertension (IAH), the abdomen is primarily 
left open in all open repairs for RAAA.  For patients treated by eEVAR, a proactive approach 
to detection and treatment of IAH is taken. This group of patients is at high risk for 
development of ACS and therefore, close monitoring of IVP and organ function is crucial in 
order to detect critical IAH. IVP measurement is initiated during EVAR and repeated every 
hour following the procedure. Intermittent IVP measurement3, 15 is carried out with a standard 
Foley catheter and volume priming with 50 ml of normal saline in the supine position during 
end expiration. The pubic symphysis serves as the zero reference point. Furthermore, urinary 
output, respiratory function and indices for bowel ischemia (lactate and LDH elevation) are
closely monitored. Surgical decompression is carried out when critical IAH is present and 
new organ dysfunction develops or when patients fulfill at least 1 criterion from table 1. In
“stable” patients, surveillance is continued as mentioned above.
The algorithm to choose the optimal type of open abdomen treatment is illustrated in figure 2.
Once the decision for OAT is made, decompressive laparotomy is performed urgently. 
Subject to the clinical findings in the abdomen, two different pathways are possible: 
temporary closure with (i) a plastic bag silo closure (“Bogota” bag)19 and conventional 
secondary dressing, or (ii) a vacuum assisted closure system (V.A.C. ®, KCI International, 
Amstelveen, The Netherlands). Key indicators for this decision are the amount or volume of 
the intraabdominal organs protruding from the abdomen due to massive swelling (figure 3) 
and suspicion of impending bowel necrosis due to prolonged ischemia from hypotension, 
compression and elevated IVP. If these factors are present, the abdomen is temporarily closed 
with a simple large sterile plastic drape or bag which makes direct visualization of the small 
bowel possible (figure 3). Furthermore, a bag silo closure provides a large reserve capacity 
allowing further intra-abdominal organ swelling without relevant IVP elevation thus 
preventing recurrent increased intra-abdominal pressure in the initial phase after 
decompression of ACS compared to other temporary abdominal closure techniques.20
Recently, the technique has been modified in order to improve the management of excessive 
fluid loss from the bag silo, still keeping its large reserve capacity (Bogota-VAC, figure 4).21
For minor bowel edema/distension, a vacuum assisted closure system is placed over a zipper 
drape (Figure 5) (Ethizip, Ethicon, Inc, New Jersey, USA). We call this technique 
VAC/ETHIZIP (VAC over ETHIZIP, described in detail below). When the bag silo is
initially applied, a second look intervention with inspection of the abdominal contents is
always performed within 1-2 days after abdominal decompression. Temporary abdominal 
closure is converted to the VAC/ETHIZIP technique when (i) the patient stabilized, (ii) IVP 
remained below 15mmHg, or (iii) organ function improved. In the situation of continued or 
even deteriorated ACS, the bag silo is applied again. Following our algorithm, stable patients 
with primary application of the VAC/ETHIZIP undergo second look interventions every 3-5
days with stepwise approximation of the fascial borders. The underlying zipper drape and the 
VAC foam are narrowed accordingly. However, in the situation of recurrent ACS during the 
latter course, the abdomen is decompressed again with the bag silo closure. The technique is 
converted back to VAC/ETHIZIP with continued fascial approximation whenever suitable
until definitive closure.
VAC/ETHIZIP Technique. The abdomen is left open after laparotomy and the zipper drape is 
placed sutureless underneath the entire abdominal wall (figure 5). The VAC (black 
polyurethane foam) is then applied over the ETHIZIP and a subatmospheric pressure of 50 
mm Hg is initiated (figure 6). The zipper drape is reused after second look interventions if 
undamaged. Partial abdominal wound closure is considered when the abdominal wall can be 
partially or totally approximated without any increase of IVP. For this purpose, the ETHIZIP 
is shaped so that the wound area covered will be smaller and smaller.  Accordingly, the size of 
the VAC foam is also reduced (to allow for a stepwise fascial approximation) and then 
reapplied. Delayed direct fascial (running suture with size 0 Maxon loop) and skin closure is
carried out when the abdomen is clinically tension free and the fascial borders can be 
completely approximated without any increase in bladder pressure. In case of prolonged OAT 
due to abdominal inflammation or infection, direct closure of the abdominal fascia may prove 
impossible. Permanent closure may then be achieved by the bilateral anterior rectus
abdominis sheath turnover flap method described by Kushimoto.22 The skin is then mobilized 
from the fascia and primarily approximated.
Results
Overall thirty day mortality for eEVAR was 13% (13/102). Reasons for death were: suicide 
(n=1), multiorgan failure (n=5), cardiac events (n=3), bleeding (n=3) and bowel ischemia 
(n=1). Thirty day mortality for the cohort without ACS was 8% (7/82) and for the cohort with 
ACS 30% (6/20).
Decompression after eEVAR for ACS was required in 20/102 (20%) patients, either during 
the intervention (n=14) or later in the ICU (n=6). Six of 20 (30%) patients requiring OAT 
died within 30 days. There was no difference in the mortality rate between the two groups 
(OAT during intervention, 4 of 14, OAT later in the ICU, 2 of 6 patients). One of these 
patients died in the operating room due to uncontrollable intraoperative decompressive 
bleeding, one due to multiorgan failure following small bowel ischemia, one due to sepsis 
following ischemic cholecystitis, two due to cardiac events and one due to pneumonia 29 days 
after the intervention. 
Five of the remaining 14 OAT patients needed a temporary abdominal closure with a plastic 
drape or bag due to massive volume increase of the abdominal content or suspicion of 
imminent bowel necrosis. In the other 9 patients, VAC/ETHIZIP was carried out primarily. A 
mean of 3.6 (min: 1, max: 12) planned second look interventions were done per patient with 
an interval between 3-5 days. No bowel lesions or fistulae were observed during OAT. Local 
bacterial contamination (positive swab) was encountered in 5 patients and abdominal 
infection requiring antibiotic therapy in 4 patients. All infections resolved under antibiotic 
therapy.
Delayed closure of the abdominal wall was achieved after a median of 6 days (min: 1 day, 
max: 47 days). In 11 patients, direct fascial closure was possible. The remaining three patients 
either received a polypropylene mesh (n=2) or a bilateral anterior rectus abdominis sheath 
turnover flap (n=1) and direct skin closure.
Discussion
ACS has been shown to be a major cause of death after endovascular and open repair for 
RAAA.2, 7, 9, 23-27 ACS related mortality rates published for open repair are generally above 
50% and up to 100%. In a recent publication, Mehta et al report a 57% mortality rate for 
patients suffering from ACS after emergency EVAR for RAAA.6 Detection and treatment of 
ACS are therefore considered life saving and mandatory.9, 24 Proactive awareness for ACS and 
consequent treatment according to our standard protocol has resulted in a low 30-day 
mortality of 13% in our patient cohort of 102 RAAA treated by endovascular means during a 
ten year period.
Prevalence of ACS was much higher in our study than reported in the current literature after 
emergency EVAR.11-14 Despite this high prevalence of ACS, the mortality was considerably 
lower in our eEVAR cohort. We speculate that the difference in the prevalence of ACS and 
the short-term mortality might in part reflect an underdiagnosis and/or undertreatment of ACS 
in many previous studies. Notwithstanding the early diagnosis and aggressive management of 
ACS, the mortality of the subgroup of patients receiving OAT was 30%. However, there was 
no difference in mortality in our study between the two groups of primary (intraoperative) 
OAT and secondary (later in the ICU) OAT as decompression laparotomy was carried out in 
all cases before organ failure occurred. This meticulous surveillance and aggressive 
management of intra-abdominal hypertension might explain the difference to the published 
data from Rasmussen et al that show a tendency to increased in-hospital mortality in the group 
of late decompression after development of ACS.9 However, the data are difficult to compare 
due to the different management of both groups (endovascular versus open repair). 
Furthermore, to date, the best timing of abdominal decompression is still unknown and should 
be subject to further investigation.
A variety of therapeutic modalities for OAT have been published over the last 20 years.23, 24, 
28-35 However, although algorithms have been proposed for the management of intra-
abdominal hypertension and abdominal compartment syndrome following open ruptured 
AAA repair, none have been proposed in the setting of eEVAR. In this article, we provide 
simple and safe clinical decision trees for OAT after successful endovascular sealing of 
RAAA as well as for choosing the optimal type of OAT according to the clinical presentation 
during the initial intervention or a secondary procedure. Key indicators are provided to help to 
initiate the best treatment available. Bowel ischemia can be easily and rapidly detected 
through the transparent plastic drape or bag fixed only loosely to the skin. Furthermore, room 
is provided for further volume increases in the abdominal contents.20 Our VAC/ETHIZIP 
technique, on the other hand, represents a simple and clean dressing that has to be changed 
every 3-5 days thus providing more comfort to the patient and less work load for the ICU or 
ward staffs. The abdominal fascia is not traumatized, as neither the zipper drape nor the foam 
are fixed by sutures at all. Delayed step-wise wound closure can be carried out with clean and 
healthy fascial margins enhancing the probability of uneventful closure without hernia 
formation. Finally, there are several benefits to the topical negative pressure VAC dressing 
techniques. This method has been shown to exert antimicrobial activity36 and to stimulate 
granulation tissue formation.37, 38 By its mechanical mode of action39, the VAC probably 
stabilizes the abdominal wall and may prevent abdominal wall retraction. VAC/ETHIZIP has 
been preferred over the prefabricated abdominal VAC system for three reasons: (i)  better 
protection of the intraabdominal content when using the ETHIZIP compared to the thin and 
porous plastic foil potentially decreasing the risk of abdominal fistulae,  (ii) better and safer 
mobilization of the patients due to a thicker and therefore more stable standard polyurethane 
foam compared to the prefabricated abdominal VAC foam possibly leading to less 
eventrations due to VAC failures, and (iii) less cost of the VAC/ETHIZIP compared to the 
commercially available dressing.
There are several limitations of this study. One limitation is the absence of a control group 
(conservative treatment) that would allow proving and quantifying the effect of the open 
abdomen treatment in RAAA patients treated by EVAR. With the acquired knowledge about 
the negative impact of untreated ACS in RAAA patients managed by open repair in the past 
years, however, we believe that it would have been unethical to randomize and not to treat 
patients to such a control group. Furthermore, the recent publication of Mehta et al supports 
the aggressive diagnostic approach and treatment of ACS by OAT in RAAA patients 
managed by eEVAR. A second limitation is the lack of a comparative group with a different 
treatment modality and/or algorithm. Thus, our study cannot answer the question whether 
there exists another, possibly more effective approach to ACS in RAAA patients treated by 
eEVAR. We believe, however, that the 13% thirty-day mortality obtained in our study with 
102 RAAA patients managed by eEVAR has proven the effectiveness of our algorithm. 
Furthermore, although relatively frequent, the total number of patients per year with ACS 
after eEVAR is relatively low and the experience would have been diluted by following too 
many algorithms and/or treatment choices. A third limitation is the lack of comparison of 
RAAA patients treated by eEVAR to open repair. Due to our algorithm, such a comparison is 
not possible as we primarily carry out OAT in all patients managed by open repair. We are 
not able, therefore, to provide evidence of the effectiveness of our general algorithm including 
all RAAA patients. Last but not least, although there is growing evidence of the mechanism of 
action of vacuum assisted wound closure therapy, our study cannot definitely prove the 
assumptions made about the beneficial action of such therapy. Further studies should, 
therefore, include and quantify parameters such as antimicrobial activity, granulation tissue 
formation and mechanical stability of the abdominal wall treated by VAC/ETIZIP.
Conclusion
The use of standardized novel techniques and a treatment protocol and algorithm for OAT 
after eEVAR for RAAA proved to be feasible and safe. It decreased the work load of the 
medical and nursing staff and enhanced patient comfort as the need for dressing changes was 
minimized.  We believe it also contributed to lower overall mortality in RAAA patients.  
Delayed direct fascial closure was possible in the majority of patients. Widespread usage of 
these systems, methods and algorithms is recommended.
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Introduction
Open abdomen treatment (OAT) is considered a life saving procedure in patients with 
abdominal compartment syndrome (ACS) after endovascular or open intervention for 
ruptured abdominal aortic aneurysms (RAAA).1-9 Since its first description by Fietsam in this 
patient cohort2, many technical reports have been published. However, clear treatment 
algorithms are still lacking and the high mortality rates published10 may reflect difficulties in 
detecting and treating ACS5. This is especially true for patients treated by emergency 
EVARendovascular aneurysm repair (eEVAR) who do not undergo a laparotomy as part of 
their primary procedure.11-14 The aim of this study is to report on our 10-years experience with 
the management of patients requiring OAT following eEVAR for RAAA. A further objective 
of this report is to provide an algorithm for the diagnosis of intra-abdominal hypertension and 
abdominal compartment syndrome and to demonstrate a standardized method for performing 
OAT.
(eEVAR) who do not undergo a laparotomy as part of their primary procedure.11-14 In this 
article we emphasize the use of  OAT in patients treated by eEVAR and present new 
standardized methods for performing OAT in patients undergoing eEVAR along with an 
algorithm for its use in this setting.  One key element in these methods is a new technique 
using a vacuum assisted wound closure system developed during our 10 year experience with 
eEVAR for RAAA.
Patients and methods
From January 1998 to April 2008, 102/212 consecutive patients with RAAA have been 
treated by eEVAR in our tertiary referral center. Mean age was 73±9 years (min:48, max 90 
*Redline Manuscript
years). Aneurysm rupture, defined as blood outside the aortic wall, was confirmed by 
computerized tomographic scans (CT angiography) in all patients. In 64 blood was present in 
the retroperitoneum, in 33 it was present in the peritoneal cavity, and in 5 it was present in the 
duodenum (aorto-duodenal fistula). Critical clinical data were prospectively collected and 
retrospectively analyzed. All patient charts were systematically reviewed retrospectively for 
details concerning ACS. The study was approved by the institutional review board. 
Patient monitoring. For all patients with RAAA but in particular for patients treated by 
eEVAR, a proactive approach to detection and treatment of intraabdominal hypertension 
(IAH) is critical. This group of patients is at high risk for development of ACS and therefore, 
close monitoring of intravescical pressure (corresponds to intraabdominal pressure (IAP) and 
organ function is crucial in order to detect critical IAH. Intravesical pressure (IVP) 
measurement was initiated during EVAR and repeated every hour following the procedure. 
Intermittent IVP measurement was carried out with a standard Foley catheter and volume 
priming with 50 ml normal saline in the supine position during end expiration.3, 15 The 
symphysismid-axillary line served as the zero reference. Furthermore, urinary output, 
respiratory function and indices for bowel ischemia (blood lactate and lactate dehydrogenase 
elevation) were closely monitored. Close surveillance of IAPIVP and organ function was 
continued in all patients either with or without abdominal decompression for the duration of 
IAH. Importantly, this surveillance was continued during the whole course of stepwise 
approximation of the fascial borders and subsequent fascial closure following abdominal 
decompression.
Open abdomen treatment. Abdominal decompression after eEVAR was done either during the 
primary intervention or secondarily in the ICU when critical intra-abdominal hypertension 
(IAH) was present.. Indication for surgical decompression was based on intra-vescical bladder 
pressure (IVP) >20 mm Hg or abdominal perfusion pressure (systemic mean pressure minus 
intraabdominal pressure) <50-60 mm Hg and new development of organ dysfunction or when 
patients fulfilled at least 1 criteriacriterion from table 1 (modified after9, 16-18)..
The general algorithm of open abdomen treatment for all RAAA patients in our institution is 
illustrated in figure 1. To avoid intra-abdominal hypertension (IAH,), the abdomen is 
primarily left open in all open repairs for RAAA.  For patients treated by eEVAR, a proactive 
approach to detection and treatment of IAH is taken. This group of patients is at high risk for 
development of ACS and therefore, close monitoring of intraabdominal pressure (IAP)IVP
and organ function is crucial in order to detect critical IAH. IVP measurement is initiated 
during EVAR and repeated every hour following the procedure. Intermittent IVP
measurement3, 15 is carried out with a standard Foley catheter and volume priming with 50 ml 
of normal saline in the supine position during end expiration. The pubic symphysis serves as 
the zero reference point. Furthermore, urinary output, respiratory function and indices for 
bowel ischemia (lactate and LDH elevation) are closely monitored. Indication for abdominal 
decompression are based on IAH>20 mm Hg in combination with deterioration of organ 
function.Surgical decompression is carried out when critical IAH is present and new organ 
dysfunction develops or when patients fulfill at least 1 criterion from table 1). In “stable” 
patients, surveillance is continued as mentioned above.
The algorithm to choose the optimal type of open abdomen treatment is illustrated in figure 2.
Once the decision for OAT is made, decompressive laparotomy is performed urgently. 
Subject to the clinical findings in the abdomen, two different pathways are possible: 
temporary closure with (i) a plastic bag silo closure (“Bogota” bag)19 and conventional 
secondary dressing, or (ii) a vacuum assisted closure system (V.A.C. ®, KCI International, 
Amstelveen, The Netherlands). Key indicators for this decision are the amount or volume of 
the intraabdominal organs protruding from the abdomen due to massive swelling (figure 3) 
and suspicion of impending bowel necrosis due to prolonged ischemia from hypotension, 
compression and elevated IAP.IVP. If these factors are present, the abdomen is temporarily 
closed with a simple large sterile plastic drape or bag which makes direct visualization of the 
small bowel possible (figure 3). Furthermore, a bag silo closure provides a large reserve 
capacity allowing further intra-abdominal organ swelling without relevant IAP 
elevation.20IVP elevation thus preventing recurrent increased intra-abdominal pressure in the 
initial phase after decompression of ACS compared to other temporary abdominal closure 
techniques.20 Recently, the technique has been modified in order to improve the management 
of excessive fluid loss from the bag silo, still keeping its large reserve capacity (Bogota-VAC, 
figure 4).21 For minor bowel edema/distension, a vacuum assisted closure system is placed 
over a zipper drape (Figure 45) (Ethizip, Ethicon, Inc, New Jersey, USA). We call this 
technique VAC/ETHIZIP (VAC over ETHIZIP, described in detail below). When the bag 
silo is initially applied, a second look intervention with inspection of the abdominal contents
is always performed within 1-2 days after abdominal decompression. Temporary abdominal 
closure is converted to the VAC/ETHIZIP technique when (i) the patient stabilized, (ii) 
IAPIVP remained below 15mmHg, or (iii) organ function improved. In the situation of 
continued or even deteriorated ACS, the bag silo is applied again. Following our algorithm, 
stable patients with primary application of the VAC/ETHIZIP undergo second look 
interventions every 3-5 days with stepwise approximation of the fascial borders. The 
underlying zipper drape and the VAC foam are narrowed accordingly. However, in the 
situation of recurrent ACS during the latter course, the abdomen is decompressed again with 
the bag silo closure. The technique is converted back to VAC/ETHIZIP with continued fascial 
approximation whenever suitable until definitive closure.
VAC/ETHIZIP Technique. The abdomen is left open after laparotomy and the zipper drape is 
placed sutureless underneath the entire abdominal wall (figure 4).(figure 5). The VAC (black 
polyurethane foam) is then applied over the ETHIZIP and a subatmospheric pressure of 50 
mm Hg is initiated (figure 5).(figure 6). The zipper drape is reused after second look 
interventions if undamaged. Partial abdominal wound closure is considered when the 
abdominal wall can be partially or totally approximated without any increase of IAP.IVP. For 
this purpose, the ETHIZIP is shaped so that the wound area covered will be smaller and 
smaller.  Accordingly, the size of the VAC foam is also reduced (to allow for a stepwise 
fascial approximation) and then reapplied. Delayed direct fascial (running suture with size 0 
Maxon loop) and skin closure is carried out when the abdomen is clinically tension free and 
the fascial borders can be completely approximated without any increase in bladder pressure
(figure 6).. In case of prolonged OAT due to abdominal inflammation or infection, direct 
closure of the abdominal fascia may prove impossible. Permanent closure may then be 
achieved by the bilateral anterior rectus abdominis sheath turnover flap method described by 
Kushimoto.2122 The skin is then mobilized from the fascia and primarily approximated.
Results
ThirtyOverall thirty day mortality for eEVAR was 13% (13/102). Reasons for death were: 
suicide (n=1), multiorgan failure (n=5), cardiac events (n=3), bleeding (n=3) and bowel 
ischemia (n=1). Thirty day mortality for the cohort without ACS was 8% (7/82) and for the 
cohort with ACS 30% (6/20).
Decompression after eEVAR for ACS was required in 20/102 (20%) patients, either during 
the intervention (n=14) or later in the ICU (n=6). Six of 20 (30%) patients requiring OAT 
died within 30 days. There was no difference in the mortality rate between the two groups 
(OAT during intervention, 4 of 14, OAT later in the ICU, 2 of 6 patients). One of these 
patients died in the operating room due to uncontrollable intraoperative decompressive 
bleeding, one due to multiorgan failure following small bowel ischemia, one due to sepsis 
following ischemic cholecystitis, two due to cardiac events and one due to pneumonia 29 days 
after the intervention. 
Five of the remaining 14 OAT patients needed a temporary abdominal closure with a plastic 
drape or bag due to massive volume increase of the abdominal content or suspicion of 
imminent bowel necrosis. In the other 9 patients, VAC/ETHIZIP was carried out primarily. A 
mean of 3.6 (min: 1, max: 12) planned second look interventions were done per patient with 
an interval between 3-5 days. No bowel lesions or fistulae were observed during OAT. Local 
bacterial contamination (positive swab) was encountered in 5 patients and abdominal 
infection requiring antibiotic therapy in 4 patients. All infections resolved under antibiotic 
therapy.
Delayed closure of the abdominal wall was achieved after a median of 6 days (min: 1 day, 
max: 47 days). In 11 patients, direct fascial closure was possible. The remaining three patients 
either received a polypropylene mesh (n=2) or a bilateral anterior rectus abdominis sheath 
turnover flap (n=1) and direct skin closure.
Discussion
ACS has been shown to be a major cause of death after endovascular and open repair for 
RAAA.2, 7, 9, 22-2623-27 ACS related mortality rates published for open repair are generally 
above 50% and up to 100%. In a recent publication, Mehta et al report a 7057% mortality rate 
for patients suffering from ACS after emergency EVAR for RAAA.6 Detection and treatment 
of ACS are therefore considered life saving and mandatory.9, 2324 Proactive awareness for 
ACS and consequent treatment according to our standard protocol has resulted in a low 30-
day mortality of 13% in our patient cohort of 102 RAAA treated by endovascular means 
during a ten year period.
Prevalence of ACS was much higher in our study than reported in the current literature after 
emergency EVAR.11-14 Despite this high prevalence of ACS, the mortality was considerably 
lower in our eEVAR cohort. We speculate that the difference in the prevalence of ACS and 
the short-term mortality might in part reflect an underdiagnosis and/or undertreatment of ACS 
in many previous studies. Notwithstanding the early diagnosis and aggressive management of 
ACS, the mortality of the subgroup of patients receiving OAT was 30%. However, there was 
no difference in mortality in our study between the two groups of primary (intraoperative) 
OAT and secondary (later in the ICU) OAT as decompression laparotomy was carried out in 
all cases before organ failure occurred. This meticulous surveillance and aggressive 
management of intra-abdominal hypertension might explain the difference to the published 
data from Rasmussen et al that show a tendency to increased in-hospital mortality in the group 
of late decompression after development of ACS.9 However, the data are difficult to compare 
due to the different management of both groups (endovascular versus open repair). 
Furthermore, to date, the best timing of abdominal decompression is still unknown and should 
be subject to further investigation.
A variety of therapeutic modalities for OAT have been published over the last 20 years.22, 23, 
27-3424, 28-35 However, standardizedalthough algorithms and treatment protocolshave been 
proposed for OAT do not exist.the management of intra-abdominal hypertension and 
abdominal compartment syndrome following open ruptured AAA repair, none have been 
proposed in the setting of eEVAR. In this article, we provide simple and safe clinical decision 
trees for OAT after successful endovascular sealing of RAAA as well as for choosing the 
optimal type of OAT according to the clinical presentation during the initial intervention or a 
secondary procedure. Key indicators are provided to help to initiate the best treatment 
available. Bowel ischemia can be easily and rapidly detected through the transparent plastic 
drape or bag fixed only loosely to the skin. Furthermore, room is provided for further volume 
increases in the abdominal contents.20 Our VAC/ETHIZIP technique, on the other hand, 
represents a simple and clean dressing that has to be changed every 3-5 days thus providing 
more comfort to the patient and less work load for the ICU or ward staffs. The abdominal 
fascia is not traumatized, as neither the zipper drape nor the foam are fixed by sutures at all. 
Delayed step-wise wound closure can be carried out with clean and healthy fascial margins 
enhancing the probability of uneventful closure without hernia formation (figure 7).. Finally, 
there are several benefits to the topical negative pressure VAC dressing techniques. This 
method has been shown to exert antimicrobial activity35activity36 and to stimulate granulation 
tissue formation.36, 37, 38 By its mechanical mode of action38action39, the VAC probably 
stabilizes the abdominal wall and may prevent abdominal wall retraction. VAC/ETHIZIP has 
been preferred over the prefabricated abdominal VAC system for three reasons: (i)  better 
protection of the intraabdominal content when using the ETHIZIP compared to the thin and 
porous plastic foil potentially decreasing the risk of abdominal fistulae,  (ii) better and safer 
mobilization of the patients due to a thicker and therefore more stable standard polyurethane 
foam compared to the prefabricated abdominal VAC foam possibly leading to less 
eventrations due to VAC failures, and (iii) less cost of the VAC/ETHIZIP compared to the 
commercially available dressing.
There are several limitations of this study. One limitation is the absence of a control group 
(conservative treatment) that would allow proving and quantifying the effect of the open 
abdomen treatment in RAAA patients treated by EVAR. With the acquired knowledge about 
the negative impact of untreated ACS in RAAA patients managed by open repair in the past 
years, however, we believe that it would have been unethical to randomize and not to treat 
patients to such a control group. Furthermore, the recent publication of Mehta et al supports 
the aggressive diagnostic approach and treatment of ACS by OAT in RAAA patients 
managed by eEVAR. A second limitation is the lack of a comparative group with a different 
treatment modality and/or algorithm. Thus, our study cannot answer the question whether 
there exists another, possibly more effective approach to ACS in RAAA patients treated by 
eEVAR. We believe, however, that the 13% thirty-day mortality obtained in our study with 
102 RAAA patients managed by eEVAR has proven the effectiveness of our algorithm. 
Furthermore, although relatively frequent, the total number of patients per year with ACS 
after eEVAR is relatively low and the experience would have been diluted by following too 
many algorithms and/or treatment choices. A third limitation is the lack of comparison of 
RAAA patients treated by eEVAR to open repair. Due to our algorithm, such a comparison is 
not possible as we primarily carry out OAT in all patients managed by open repair. We are 
not able, therefore, to provide evidence of the effectiveness of our general algorithm including 
all RAAA patients. Last but not least, although there is growing evidence of the mechanism of 
action of vacuum assisted wound closure therapy, our study cannot definitely prove the 
assumptions made about the beneficial action of such therapy. Further studies should, 
therefore, include and quantify parameters such as antimicrobial activity, granulation tissue 
formation and mechanical stability of the abdominal wall treated by VAC/ETIZIP.
Conclusion
A The use of standardized system, novel methodstechniques and algorithms for the use of 
OAT in the management of RAAA by emergency EVAR helps to facilitate patient care and 
improvea treatment outcomes. The VAC/ETHIZIP technique enhances patient safetyprotocol
and algorithm for OAT after eEVAR for RAAA proved to be feasible and well-being and 
decreases staff safe. It decreased the work load. of the medical and nursing staff and enhanced 
patient comfort as the need for dressing changes was minimized.  We believe it also 
contributed to lower overall mortality in RAAA patients. Delayed direct fascial closure iswas
possible in the majority of patients. Widespread usage of these systems, methods and 
algorithms is recommended.
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Dear Reviewers
Thank you very much for your valuable input that helped to improve our 
article. We have addressed all the issues and answered your questions (see 
comments in red after the questions).
Sincerely yours, Dieter Mayer
Reviewer's comments:
Reviewer #1: Title: Techniques and algorithms for open abdomen treatment 
after emergency EVAR for ruptured abdominal aortic aneurysms
Summary of manuscript: The manuscript provides results from a decade's 
experience with the endovascular management of ruptured abdominal aortic 
aneurysm. The retrospective case series of 102 patients focuses on the 
clinical phenomenon of intra-abdominal hypertension and abdominal 
compartment syndrome and the use of open abdomen treatment (OAT) in this 
setting. The report provides guidelines as to the detection and diagnosis 
of this morbid condition as well as technical details related to its 
management. Based on the findings of this experience the manuscript 
suggests that use of standardized treatment protocols for OAT after 
endovascular repair of ruptured aneurysms enhances patient safety and 
quality of life and minimizes hospital (ICU) work load as well as 
morbidity and mortality.
Comments of specific manuscript sections:
1. Title:
*Review Response Form
*a. The title should be made more concise and not include the abbreviation 
EVAR. Given the content of the manuscript the technique and algorithms 
could be combined to the term "recommendation". For example: "Open abdomen 
treatment following endovascular repair of ruptured abdominal aortic 
aneurysms: recommendations from a 10-year experience"
Corrected. Thank you very much for the excellent title.
2. Abstract
a. Although the abbreviation EVAR is familiar to most, it should still be 
spelled out as endovascular aneurysm repair before the use of the 
abbreviation in line 7, page 2.
Corrected.
*b. To shorten the abstract the sentence beginning on line 18, page 2 
"Criteria for employing the plastic bag...." should be omitted and 
provided in the manuscript. In general the abstract is too long and 
provides too much detail some of which should be saved for the manuscript.
Addressed as requested.
c. Similarly, the sentence beginning on page 3, line 4 detailing the 
causes of death "One of these patients died in the operating room, due 
to....." can be omitted from the abstract.  Details such as this can be 
provided in the manuscript results.
Addressed as requested.
*d. Was the mortality different between those patients who received 
primary OAT (N=14) versus those who had it performed in the delayed period 
(N=6)? Other reports (Rasmussen, et al. JVS 2002;25:246) have suggested 
that late OAT performed after intra-abdominal compartment syndrome has 
developed is associated with higher rates of multiple organ failure and 
even mortality compared to early or 'prophylactic' performance of OAT. Was 
this examined in this study?
Unlike Rasmussen, mortality for the two groups was the same. We cancelled 
the term “delayed” as this might have contributed to some 
misunderstandings. Secondary OAT was not really delayed as it was carried 
out as soon as the bladder pressure started to rise above the critical 
point and before severe organ dysfunction appeared. We believe that this 
explains the similarity of the two groups.
e. When the abstract states that "delayed closure of the abdomen was 
achieved after a median of 6 days" does this mean fascial closure or 
absorbable mesh closure with skin grafting or a mixture of both 
techniques?
Addressed as requested and specified in text.
*f. Although this experience is valuable, the conclusions of the abstract 
overstate what can be gleaned from the results.  Specifically it cannot be 
determined whether or not OAT "enhanced patient safety".  How was this 
determined?  Nothing in the results speaks to improved quality of life. 
Improved quality of life compared to what?  Was there a comparison made 
between OAT and patients who did not undergo OAT; or between patients who 
received early OAT versus those that received late OAT? The conclusion 
should be revised understanding that there were no group comparisons made 
in the methods.  Therefore the most that can be concluded is the 
feasibility and safety of the technique and basic outcomes associated with 
use of the technique and algorithm. 
Addressed as requested. However, had we not treated the patients early due 
to early detection and aggressive algorithms, the 14 survivors would have 
died due to multiorgan failure following ACS.Quality of life was not 
quantified, but the patients expressed extreme gratitude that they did not 
have to change the dressings for several days (most of them were awake 
with no respiratory aid) and that they could walk around (some even went 
to the hospital bar to drink coffee) without restriction.
3. Introduction:
a. Although EVAR is understood by most, the words "endovascular aneurysm 
repair" should precede its use in the introduction.
Addressed as requested.
*b. The objective of this manuscript should be more clearly stated 
emphasizing the strengths of the study at the end of the introduction. For 
example: "The aim of this study is to report on 10-years experience with 
endovascular management of ruptured abdominal aortic aneurysms. 
Specifically the objective is to describe a sub-analysis patients 
requiring OAT following eEVAR for ruptured AAA.  Lastly the objective of 
this report is to provide an algorithm for the diagnosis of intra-
abdominal hypertension and abdominal compartment syndrome and to 
demonstrate a standardized method for performing OAT."
Addressed as proposed. Thank you very much.
4. Methods:
a. As currently written the methods include several findings from the 
clinical series that should be in the results section.  Specifically the 
age and findings at laparotomy (e.g. percentage of patients that had 
hemoperitoneum versus retroperitoneal versus duodenal blood) should be in 
results.
As you correctly pointed out above, this study is intended as a subgroup 
analysis of (20) RAAA patients managed by eEVAR and suffering from ACS. 
Furthermore, the article concentrates on standardized algorithms for OAT. 
The short description of the overall cohort just serves to understand what 
kind of patients we are talking about and how the findings and algorithms 
should be put into perspective. We suggest, therefore, to leave this short 
description unchanged in the methods section.
b. During several sections of the manuscript there appears to be an auto 
notation system placing the words "Error! Refernce source not found" in 
the text of the manuscript. For example, line 20 of page 2, and lines 7 
and 8 and 16 and 17 of page 3 have this error which should be corrected 
throughout.
Corrected.
*c. Do the methods allow for comparison of the cohort of patients who 
underwent early or prophylactic OAT (N=14) versus those that underwent 
late or emergent OAT (N=6)? If not, why not? Previous studies have shown 
the value of early or prophylactic OAT before the adverse effects of 
intra-abdominal compartment syndrome have had the opportunity to serve as 
the "second hit" to an already compromised patient. The numbers are small 
enough in both groups (14 and 6) that perhaps basic comparisons could be 
at least acknowledged.
As stated out above (abstract section), the two groups did not differ and 
the term “delayed” OAT was misleading. We added a sentence in the results 
section: “There was no difference in the mortality rate between the two 
groups (OAT during intervention, 4 of 14, OAT later in the ICU, 2 of 6 
patients).”
5. Results
*a. The final line of the results section (lines 14 and 15, page 5) refers 
to "delayed closure of the abdominal wall was achieved after a median of 6 
days".  Were all of these fascial closures or were some achieved with the 
use of vicryl or other mesh sewn to the fascia?  Were there any 
dehiscenses or fascial breakdowns?  And what is the follow up of this 
patient cohort or at least those with the OAT?  This would be important to 
know given that the technique is touted to improve quality of life and 
have low rates of infection.
In 11 patients, direct fascial closure was possible. The remaining three 
patients either received a polypropylene mesh (n=2) or a bilateral 
anterior rectus abdominis sheath turnover flap (n=1) and direct skin 
closure.
Long-term follow up was not the aim of the study. We are currently working 
on a long-term follow-up of the whole cohort for different aspects (long-
term survival, reinterventions, endoleaks and so on). This has not been 
completed, yet and is subject to a separate paper.
6. Discussion
*a. Line 5, page 6 is not entirely correct as reference 9 does lay out an 
algorithm based on a case control study of patients with open abdomen 
treatment following open ruptured AAA repair. This sentence should be 
modified to state that "although algorithms have been proposed for the 
management of intra-abdominal hypertension and abdominal compartment 
syndrome following open ruptured AAA repair, none have been proposed in 
the setting of eEVAR."
Corrected. Thank you for your nice proposal.
*b. In light of what has been published about intra-abdominal hypertension 
and abdominal compartment syndrome the discussion should include the 
preference of timing of OAT.  Is it the authors' experience that early or 
prophylactic OAT is better than delayed OAT performed after intra-
abdominal compartment syndrome has developed? Or is OAT equally effective 
irrespective of timing?  This experience should be compared and or 
contrasted to previously published work on this topic.
The term “delayed” was misleading. We did not wait for ACS to develop but 
decompressed as soon as bladder pressure reached a critical point before 
severe organ dysfunction developed. Added a section about the issue in the 
discussion.
c. Do the authors have any comment on final closure techniques?  
Specifically when fascial closure was accomplished did they prefer use of 
interrupted sutures to prevent fascial strangulation? Was there ever use 
of retention sutures?  Were there any early dehiscenses in the cohort?  
And was vicryl mesh ever used to achieve abdominal domain in those 
patients in whom the fascia would not approximate?
Fascial closure was always done with a size 0 Maxon running suture(added 
under methods). No renetion sutures were used. No early dehiscence ocured. 
Polypropylene mesh has been used in 2 patients (added in text, see above).
*d. Similar to the conclusions of the abstract the conclusions of the 
manuscript on page 8 should be careful not to overstate what this 
retrospective non-case control study does show.  Specifically, and as the 
limitation paragraph points out, without comparisons within the cohort it 
is not possible to say that this technique "improved treatment outcomes" 
or "enhanced patient safety" or "decreases staff work load".  While these 
authors may find this technique useful it may be that other techniques to 
manage the open abdomen after ruptured AAA may be just as effective.  The 
strength of this experience lies in the fact that it is one of the first 
to report this following eEVAR and it is sizable and over a considerable 
period of time.  The conclusions would be more impactful if they stuck 
with these strengths and didn't overstate the findings.
Corrected as in abstract (see above)
8. Legends:
*a. The legend for Table 1 should include the references of the papers 
from which these criteria were drafted.  The legend may include a 
statement such as: "modified from references, 9 and 16-18."
Done.
9. Tables:
*a. The references from which the factors in Table 1 were compiled should 
be noted or acknowledged in the Table legend or key.
Done.
10. Figures:
*a. The diamond in the middle of Figure 1 that refers to "signs of or risk 
for ACS" should have a asterisks following the word "risk" that directs 
the reader to Table 1 which lists the clinical risk factors for ACS based 
on previous publications.
Done. Thank you!
b. Figures 6 and 7 should be omitted as they do not add significantly to 
the report. Although interesting with 7 figures these should at the least 
be omitted to decrease the length of the manuscript.
Omitted.
Reviewer #2: The authors describe their experience with a large number of 
patients with ruptured AAA treated with stent grafts. In their paper they 
focus on abdominal compartment syndrome as a major predictive parameter 
determining survival. Reading the paper there are a number  of  questions:
*1.The authors do not  mention any problems with deploying the stent graft  
in any case, did they not  have patients with no neck suitable for EVAR or 
highly calcified iliac arteries prohibiting an endovascular     approach -
if yes how did  they manage these cases.
The aim of this article being subgroup analysis of the ACS cohort and the 
proposal of standardized algorithms, we have avoided technical details 
about eEVAR. Over the last decade, we have done roughly 50% of our RAAA 
cases with eEVAR, although this rate has increased up to 88% this year. 
According to our intention-to-treat protocol we adhere to an “eEVAR 
whenever possible” approach. Fortunately, we never encountered bilaterally 
inaccessible iliacs. When monolaterally accessible, we have taken AUI 
devices. The open repair group are all juxta- to suprarenal AAAs.
*2.  What kind of grafts were primarily used, do they prefer uniiliac 
versus bifurcated grafts , please explain.
92 bifurcated, 9 AUI, 1 cuff. We prefer bifurcated endografts as they are 
more durable. Furthermore, it is more like our “daily business” and we 
feel more versatile. However, AUI are great and should be used according 
to the needs and preferences and by less experienced groups.
*3.  102 patients were treated with EVAR  the 14 OAT cases are those who 
were converted immediately after EVAR still in the  operating room?
I hope, I get the question right. We had 20/102 eEVAR cases that underwent 
OAT. 14 directly in theatre, 6 later on in the ICU. We have clarified the 
issue, I hope, in the revised text.
4   What happened to the 110 patients treated  with conventional surgery , 
what is the mortality in this group compared to endovascular,?
The mortality of this group is 33%. However, the groups are not 
comparable: the open repair group are all juxta- to suprarenal AAAs.
5   What  kind of protocol did they base their decision on whom to treat 
with EVAR and who not?
We have an intention-to-treat protocol. The exclusion criteria are only 
anatomical (see graph below).
*6.  Please define abdominal perfusion pressure, do you mean systemic mean 
pressure
Abdominal perfusion pressure (APP) is defined as the result of the 
systemic mean pressure minus the compartment pressure (and, academically, 
minus the central venous pressure). Recommendations are (Intensive Care 
Med (2007) 33:951–962), to keep APP at 50-60 mm Hg (in our text there was 
a mistake telling >60). Added to text and corrected.
*7   How do you make sure that the Zipper drape stays in place when it is 
not sutured to the abdominal wall.
You cannot be 100% sure. However, by now, this hasn’t been an issue. We do 
not cut the zipper drape and unfold it symmetrically underneath the 
abdominal wall (on top, you have to incise the hepatic ligaments). Then we 
apply the normal thick PU foam and fix it again widely to the abdomen with 
a large overlap of the sticking foil.
*8.  Please describe more in detail how the intravesical pressure is 
measured.
50 ml normal saline is instilled into the bladder. Then, the catheter is 
punctured with a needle at the prefabricated silicone membrane site, and 
everything is connected to the monitor, temporarily using the central 
venous pressure measurement line. The pressure is then measured in the 
supine position during end expiration. The mid-axillary line served as 
zero reference. Alternatively, a classic water column may be used. The 
references are added in the methods section.
*9.  According to Table 1 most patients with ruptured AAA fulfill the 
criteria for an open abdominal  wound treatment, do they have more precise 
parameters in their clinical practice which should be mentioned ?
We fully agree for open repair! However, for eEVAR things seem different 
to us. We do generally avoid transfusions and infusions (hypotensive 
hemostatic approach) whenever possible. Patients rarely get cold as they 
are fully covered with warm sheets during eEVAR. Retroperitoneal hematomas 
have to be vast and bowel swelling massive AND bladder pressure has to be 
high or APP low. We agree, however, that for every patient the decision 
has to be individually taken.
*10  There are some redundancies when describing the  different drape and 
VAC techniques.
We have tried to be concise. Can you help us what you would like to see 
omitted? 
*11  Did they use a transparent bowel bag to be able to inspect the 
bowel,. Using a similar technique we always have a problem with excessive 
fluid loss, did they find a way to prevent it?
No, fluid is always lost. But we have found a way to keep things more 
manageable. You can handcraft a small circle with the black PU foam and 
apply topical negative pressure (VAC) just at the border of the bag silo 
where it is attached to the skin. By that way at least everything remains 
clean and dry and bacterial contamination is minimized. (Alternatively, 
you can take part of the prefabricated abdominal VAC system, although we 
think it is too expensive taking only parts of it.)
Added a sentence, reference and figure for the method in the methods 
section.
Reviewer #3: This paper describes an algorithm for open abdominal 
treatment for abdominal compartment syndrome (ACS) after EVAR for ruptured 
abdominal aneurysms and an original concept to reduce the intra abdominal 
pressure.  Whether this concept is efficient remains to be demonstrated. 
The authors claim that the low mortality is the proof that the concept 
works. The 13 % mortality rate is impressive, however when a comparison is 
made between mortality of patients treated for ACS and mortality of 
patients without ACS we found 6/20 (30%) and 7/82 (8%) which is less 
convincing.   Obviously we cannot presume the mortality rate had the 
decompressive measures not been undertaken.  In the discussion section the 
authors recognized honestly the limitation of the study. One way to 
demonstrate the efficiency of the measures would be a more detailed 
description of the evolution of patient following the opening of the 
abdomen. * Since a thorough surveillance of quantitative parameters
has been performed, tables showing the evolution of the parameters would 
be useful tools to convince readers.
Untreated ACS has a reported mortality of 100%. We therefore believe that 
we reduced the mortality rate for this subgroup by 70% (or a little bit 
less would some patients maybe have died even without OAT).
The reasons for death were manifold: One of these patients died in the 
operating room due to uncontrollable intraoperative decompressive 
bleeding, one due to multiorgan failure following small bowel ischemia, 
one due to sepsis following ischemic cholecystitis, two due to cardiac 
events and one due to pneumonia 29 days after the intervention. None of 
the patients died due to classical multiorgan failure. We believe, 
therefore, that further tables would not add to the knowledge but rather 
lengthen the article and make it less concise.
Abstract: too long should be limited to algorithm description and facts. 
Limitation of the study should be added.
Shortened. We have not added the limitations as they cannot stay without 
explanation, we think. With explanation, the abstract will be way too long 
again.
Patients and method   
* Give criterion section for EVAR versus open repair What was the 
mortality of open repair?
The aim of this article being subgroup analysis of the ACS cohort and the 
proposal of standardized algorithms, we have avoided a detailed 
description of eEVAR. Our intention-to-treat protocol, however, specifies 
that every patient that can be done anatomically will be done by eEVAR. 
For exclusion criteria see graph below. Mortality for OR was 33%.
* Some demographics would enhance the manuscript: gender age and risk 
factors
The aim of this article being subgroup analysis of the ACS cohort and the 
proposal of standardized algorithms, we have avoided a detailed 
description of demographics. Further text and/or tables would lengthen the 
manuschript. We were already asked to omit text and figures.
* Details of transfusion, stay in ICU, total LOS and post operative 
complications are needed
Please see comments above.
* Page 2 line 17 Define the abdominal perfusion pressure
Defined.
Page 2 line 4 how is measured intra abdominal pressure (IAP) is it 
different from intra bladder pressure? If not delete   IAP to facilitate 
the reading. 
* Page 2 line 21 to page 3 line 3 is a copy of page 2 line 1 to 8!!!! 
Delete one of them 
Deleted IAP and replaced with IVP.
Results
* Page 4 line 23 Divide mortality according to the presence or not of ACS 
Page 5 same comment as above
Done.
* Give the evolution of intra vesical pressure over time and the evolution 
of the other parameters
Decompression was done as soon as bladder pressure rose >20 mm Hg or when 
APP fell below 60 mm Hg. After decompression, bladder pressure was below 
these values in all patients. Furthermore, the reasons for death were 
manifold: One of these patients died in the operating room due to 
uncontrollable intraoperative decompressive bleeding, one due to 
multiorgan failure following small bowel ischemia, one due to sepsis 
following ischemic cholecystitis, two due to cardiac events and one due to 
pneumonia 29 days after the intervention. None of the patients died due to 
classical multiorgan failure. We believe, therefore, that further tables 
would not add to the knowledge but rather lengthen the article and make it 
less concise.
* Was it any complication related to the technique: fistula, infection, 
abundant extra vasation of liquid?
No fistulae (added in text), infections already described in text (4 
patients, all resolved with conservative (antibiotic) management. No 
excessive fluid loss with VAC/ETHIZIP.
Discussion: 
Page 7 line 4 a table with a literature review of mortality linked to ACS
As we have already been asked to omit figures and text in order to keep 
the article short and readable, we hesitate to add another table. We have, 
however, added a line “ACS related mortality rates published for open 
repair are generally above 50% and up to 100%”. We are not sure whether 
such a table adds much to the understanding of this subgroup analysis or 
the suggested algorithms and suggest to leave it up to the editor whether 
we should add a table as shown below.
Page 7 line 19 what is the rational for OAT in all patients treated by 
open surgery?
Mortality of open repair is still 50% and unchanged for 5 decades. The 
major reason for death seems to be multiorgan failure which we believe is 
cause by ACS. Although there is no proof possible from our data, we think 
there is clinical evidence that our mortality after open repair 
significantly decreased since adhering to our proposed algorithm, namely 
to leave all abdomens open after open repair. We acknowledge, however, 
that the discussion is going on and that this is subject to further 
investigations.
* Conclusion should be soften since there is no data to prove the 
efficiency of the method
Done.
Reviewer #4: General comments
Interesting set of data on abdominal decompression after emergency EVAR. 
However the structure of the data can be improved and several questions 
can be asked (see below). There are also some textual problems (see 
below).
The problem of abdominal compartment syndrome after acute AAA is well 
known for open repair, but limited knowledge exists after eEVAR.
The number / percentage of patients in this study seem rather high and 
there might be a definition problem.
The rate of ACS exactly corresponds to the numbers published for open 
repair as well as for emergency EVAR (Metha et al). We strictly adhere to 
the criteria of the World Society of the Abdominal Compartment Syndrome 
(see http://www.wsacs.org/).
Furthermore there is a risk of overtreatment of these patients
See comment above. Furthermore, the ACS related reported mortality rates 
(including eEVAR) are above 50% and up to 100% as opposed to 30% in our 
study.
The aim and objective of the study must be clarified more clearly.
Done.
It seems that a evaluation of operated patients is used to propose 
management, but the patient group is limited.
This is to our knowledge the biggest series of eEVAR worldwide. Moreover, 
as you can see from the table above, the number of ACS patients is second 
in the literature.
The wound management system attributes very little to the clinical issue.
Although we agree that many different systems may lead to good results as 
well, we believe that our system has advantages as discussed in the text.
In material and methods it is not clear how the data were collected and 
how the data were checked. In the material and methods many statements are 
made, that should be addressed in the discussion. Further:
- What is the result of the review system of the data?
- What was the indication for eEVAR?
- How was resuscitation performed, was there a protocol?
- If data were collected prospectively, what were the Hardman 
criteria?
- how was the abdominal perfusion pressure measured of calculated?
Regarding result of the review system, I am not sure whether I understand 
your question right. Data were collected prospectively and reviewed by the 
group. We cross checked several data sets (hospital charts, ICU 
information system, Dendrite database, Swissvasc database) retrospectively 
and found no inconsistency.
We have an intention-to-treat protocol. The exclusion criteria are only 
anatomical (see graph below).
We do generally avoid transfusions and infusions (hypotensive hemostatic 
approach) whenever possible.
As the Hardman index is not a reliable predictor of outcome following 
repair of ruptured abdominal aortic aneurysm (Sharif MA, Arya N, Soong CV, 
Lau LL, O'Donnell ME, Blair PH, McKinley AG.Ann Vasc Surg. 2007 
Jan;21(1):34-8.), we do not calculate it.
Abdominal perfusion pressure (APP) is defined as the result of the 
systemic mean pressure minus the compartment pressure (and, academically, 
minus the central venous pressure). Recommendations are (Intensive Care 
Med (2007) 33:951–962), to keep APP at 50-60 mm Hg (in our text there was 
a mistake telling >60). Added to text and corrected.
Results:
- Why are the results of the open repair not mentioned? What is the 
mortality in that group? Since in the open repair open abdomen was 
standard practice, the experience with the open abdomen techniques would 
be interesting, at least some overall results.
The two groups are not comparable. eEVAR was done in infrarenal, open 
repair in all other (juxta- to suprarenal) RAAAs. Moreover, the algorithms 
are not alike as we leave all abdomens open in open repair. OR mortality 
rate is 33%.
- One patient with an open abdomen was repaired the next day: probably 
the open abdomen therapy
In this patient, a significant negative fluid balance was achieved within 
24 hours and bowel swelling decreased significantly. Moreover, the 
retroperitoneal hematoma was removed so that we were able to directly 
close the abdomen.
In the discussion some issues need clarification:
- why is the cut-off point for open abdomen chosen at 20mm Hg: seems 
to result in overtreatment of many patients?
We strictly stick to the rules of the World Society of the Abdominal 
Compartment Syndrome (see http://www.wsacs.org/ and
http://www.wsacs.org/Images/ACS_management.pdf).
- Why are all open repairs primarily treated with an open abdomen? 
Literature on this issue does not support this policy as a standard 
procedure with a risk of additional morbidity
Mortality of open repair is still 50% and unchanged for 5 decades. The 
major reason for death seems to be multiorgan failure which we believe is
cause by ACS. Although there is no proof possible from our data, we think 
there is clinical evidence that our mortality after open repair 
significantly decreased since adhering to our proposed algorithm, namely 
to leave all abdomens open after open repair. We acknowledge, however, 
that the discussion is going on and that this is subject to further 
investigations.
- What are the risks / cons of the vac/ethizip technique over standard 
procedures? What is the evidence?
There is no firm evidence of pros or cons VAC/ETHIZIP from our data. 
However, we have not encountered major complications so far. Especially, 
we have not seen any enteric fistula, bleeding or severe abdominal 
infection. We can see no other risks or contraindications for this method 
than the initial huge swelling of abdominal organs or bowel ischemia where 
we suggest starting with a Bogota bag.
- The ACS diagnosis in this series is very high probably because of 
the relatively low threshold for open abdomen treatment: should be 
commented on.
We strictly stick to the rules of the World Society of the Abdominal 
Compartment Syndrome (see http://www.wsacs.org/ and
http://www.wsacs.org/Images/ACS_management.pdf). We and other authors 
believe that ACS is probably underdiagnosed.
Figure 1. General algorithm
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Figure 1. General algorithm for open abdomen treatment after eEVAR for RAAA
Legend. RAAA=Ruptured abdominal aortic aneurysm, EVAR=Endovascular aneurysm repair, 
ACS=Abdominal compartment syndrome. *For risks, see Table 1.
Figure 2. Algorithm to choose optimal type of open abdomen treatment after eEVAR for RAAA.
Legend. OAT=Open abdomen treatment, w/o=without, VAC=Vacuum assisted closure, 
VAC/ETHIZIP=VAC-over-ETHIZIP.
Figure 3. Temporary abdominal closure with a simple large sterile plastic drape or bag allows direct 
visualization of the bowel and further swelling of the abdomen without pressure rise.
Figure 4. A ring shaped black polyurethane (PU) foam of the VAC system is put near the border 
where the Bogota bag is sutured to the skin. The adhesive foils just cover the PU foam, not the whole 
bag silo. The TRAC-PAD® of the VAC system is positioned so that it doesn’t interfere with the bag 
or skin.
Figure 5. Zipper drape placed sutureless underneath the entire abdominal wall.
Figure 6. Polyurethane foam applied over the ETHIZIP with suction of 50-100mm Hg.
Table 1. Predisposing factors for ACS (modified from references9, 16-18).
Legend. BP=Blood pressure, RBC=Red blood cell concentrates, 
Figure/Table Legend
Table 1: Predisposing factors for ACS
 Deep shock:
Systolic BP < 70mm Hg during 20 minutes
+/- Hb < 8 g/dl
+/- pH < 7.3
 Intraoperative fluid infusion > 5 L
 Transfusion > 6 RBC
 T < 35 Grade Celsius
 Vast retroperitoneal hematoma
 Massive bowel swelling
Table 1 Predisposing factors for ACS
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